Morphological intratumor heterogeneity in ductal carcinoma in situ of the breast
- PMID: 33502600
- DOI: 10.1007/s00428-021-03040-6
Morphological intratumor heterogeneity in ductal carcinoma in situ of the breast
Abstract
Ductal carcinoma in situ (DCIS) of the breast is a heterogeneous disease in terms of morphological characteristics, protein expression profiles, genetic abnormalities, and potential for progression. Molecular heterogeneity has been extensively studied in DCIS. Yet morphological heterogeneity remains relatively undefined. This study investigated morphological intratumor heterogeneity in a series of 51 large DCIS. Nuclear atypia, DCIS architecture, necrosis, calcifications, stromal architecture, and stromal inflammation were assessed in one biopsy slide and three representative slides from each corresponding resection. For each histopathological feature, a histo-score was determined per slide and compared between the biopsy and the resection, as well as within a single resection. Statistical analysis comprised of Friedman tests, post hoc Wilcoxon tests with Bonferroni corrections, Mann-Whitney U tests, and chi-square tests. Despite substantial morphological heterogeneity in around 50% of DCIS, the histopathological assessment of the biopsy did not statistically significantly differ from the resection. Morphological heterogeneity was not significantly associated with patient age, DCIS size, or type of surgery, except for a weak association between heterogeneous stromal inflammation and smaller DCIS size. At the group level, the degree of heterogeneity did not significantly affect the representativity of a biopsy. At the individual patient level, however, the presence of necrosis, intraductal calcifications, myxoid stromal changes, and high-grade nuclear atypia was underestimated in a minority of DCIS patients. This study confirms the presence of morphological heterogeneity in DCIS for all six evaluated histopathological features. This should be kept in mind when taking biopsy-based treatment decisions for DCIS patients.
Keywords: Breast; Ductal carcinoma in situ; Histopathology; Intratumor heterogeneity; Tumor-infiltrating lymphocytes.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.
Similar articles
-
Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.Mod Pathol. 2020 Mar;33(3):354-366. doi: 10.1038/s41379-019-0367-9. Epub 2019 Sep 18. Mod Pathol. 2020. PMID: 31534203 Free PMC article.
-
Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast.Eur J Surg Oncol. 2019 Apr;45(4):550-559. doi: 10.1016/j.ejso.2018.11.005. Epub 2018 Nov 12. Eur J Surg Oncol. 2019. PMID: 30454971
-
[Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].Pathologica. 2002 Dec;94(6):299-305. doi: 10.1007/s102420200053. Pathologica. 2002. PMID: 12540993 Italian.
-
Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.Hum Pathol. 2016 Mar;49:114-23. doi: 10.1016/j.humpath.2015.11.003. Epub 2015 Nov 17. Hum Pathol. 2016. PMID: 26826418 Review.
-
The effect of margins on the clinical management of ductal carcinoma in situ of the breast.J Surg Oncol. 2008 Dec 15;98(8):579-84. doi: 10.1002/jso.21041. J Surg Oncol. 2008. PMID: 19072848 Review.
References
-
- McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, Sneige N, Moughan J, Shah A, Germain I, Hartford AC, Rashtian A, Walker EM, Yuen A, Strom EA, Wilcox JL, Vallow LA, Small W Jr, Pu AT, Kerlin K, White J (2015) RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol 33:709–715 - PubMed - PMC - DOI
-
- Allred DC, Mohsin SK, Fuqua SAW (2001) Histological and biological evolution of human premalignant breast disease. In: Endocrine-Related Cancer. Endocr Relat Cancer, pp 47–61
-
- Agahozo MC, Westenend PJ, van Bockstal MR et al (2020) Immune response and stromal changes in ductal carcinoma in situ of the breast are subtype dependent. Mod Pathol 33:1173–1782
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical